Insider Purchases: Inside the Buy
Tag: insider buying
Novocure (NVCR): From Electric Fields to Fighting Cancer — and Maybe Lifting Portfolios?
Novocure is zapping cancer cells with Tumor Treating Fields — and maybe giving investors a shock of opportunity. With insiders and institutions piling in, can NVCR rebound 94% from its crash? ⚡📈
Revisiting Why MSCI’s CEO Bought Shares Multiple Times Over the Past Year
MSCI’s CEO has spent over $11M buying shares in the past year. With institutions holding nearly 95% and margins above 60%, is MSCI worth the premium?
Lyft’s CEO Keeps Buying Shares. Are They About to Lift Off?
Lyft’s CEO keeps buying stock while hedge funds pile in. With profits, free cash flow, and share buybacks, could LYFT finally lift off—or hit roadblocks? 🚗📈
CEO, CFO, COO, and President, CooperVision, Are All Buying Shares of The Cooper Companies. Should You?
The CEO, CFO, COO, and President of CooperCompanies all just bought shares. Insiders, institutions, and even the company itself are betting on the stock. Value play or just another lens cleaner? 👓💸
Can LKQ Replace Bear Parts with Bull Run: Insiders Think So
Insiders are wrenching their way into LKQ stock, and institutions hold more shares than exist (!). With profits intact, dividends rolling, and valuation gauges flashing cheap, could this be the ultimate rebuild? Or is it just another jalopy on Wall Street’s lot? 🛠️📉➡️📈
It’s Not Just Team Work: Atlassian Insider Invests Too
Atlassian (TEAM) isn’t just about team work—it’s insider work too. With new insider buys, strong institutional backing, and double-digit revenue growth, is TEAM ready to rally, or will competition and valuation risks keep it swiping left?
BellRing Brands (BRBR): Insider Sips, Protein Shakes, and Market Jitters
BellRing Brands (BRBR), maker of Premier Protein and Dymatize, has insiders buying stock while institutions double down. Sales are up, but lawsuits, debt, and competition are shaking things up. Value play or value trap?
Can Olin Cock Its Stock? Insiders Say Yes (Lock, Load, and Maybe Profit)
Olin ($OLN) insiders are loading up on shares while institutions already own 94% of the float. Profits are weak, ammo is hot, and bleach is… bleach. Can this 132-year-old company cock its stock for a rebound?
Is Boeing Ready to Fly?
Boeing’s new director — ex-Vanguard CEO Tim Buckley — just bought nearly $500K of stock. With a $619B backlog and cash flow stabilizing, is this aerospace giant finally ready for liftoff… or more turbulence?
Amrize Will Rise, Insiders Undoubtedly Think
Amrize insiders are loading up on stock like it’s on sale at Home Depot. With infrastructure and housing tailwinds, it’s tempting — but watch out for valuation cracks.